After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Immuneering Corp is $150.42M. A total of 0.56 million shares were traded on the day, compared to an average of 1.21M shares.
In the most recent transaction, HAUSMAN DIANA bought 3,000 shares of IMRX for 3.62 per share on Jul 02 ’25. After the transaction, the Director now owns 3,000 company shares. In a previous transaction on Jul 02 ’25, HAUSMAN DIANA bought 2,500 shares at 3.60 per share. IMRX shares that Director owns now total 2,500.
Among the insiders who bought shares, Neufeld Leah R acquired of 700 shares on Jul 02 ’25 at a per-share price of $3.57. This resulted in the CHIEF PEOPLE OFFICER holding 10,729 shares of IMRX after the transaction. In another insider transaction, Zeskind Benjamin J. bought 7,015 shares at $3.53 per share on Jul 02 ’25. Company shares held by the PRESIDENT AND CEO now total 2,312,852.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, IMRX has a high of $4.60 and a low of $1.00.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. IMRX’s latest balance sheet shows that the firm has $149.20M in Cash & Short Term Investments as of fiscal 2021. There were $5.36M in debt and $5.63M in liabilities at the time. Its Book Value Per Share was $1.16, while its Total Shareholder’s Equity was $155.98M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMRX is Buy with a score of 4.50.
